Alcoholic hepatitis: How far are we and where are we going?
Journal Title: Annals of Hepatology - Year 2016, Vol 15, Issue 4
Abstract
The burden of alcoholic liver disease continues to be a major public health problem worldwide. The spectrum of disease ranges from fatty liver to cirrhosis and hepatocellular carcinoma. Alcoholic hepatitis (AH) is a type of acute-on-chronic liver failure and the most severe form of alcoholic liver disease. Severe AH carries a poor short-term prognosis and its management is still challenging, with scarce advances in the last decades. Corticosteroids are still the first line of therapy in severe cases. Unfortunately, many patients do not respond and novel targeted therapies are urgently needed. Liver transplantation has shown extraordinary results in non-responders to corticosteroids however; its applicability is very low. This review summarizes the epidemiology, natural history, risk factors and pathogenesis of alcoholic liver disease with special focus on the latest advances in prognostic stratification and therapy of patients with alcoholic hepatitis.
Authors and Affiliations
Verónica Prado, Joan Caballería, Víctor Vargas, Ramón Bataller, José Altamirano
Keywords
Related Articles
- EP ID EP78590
- DOI 10.5604/16652681.1202885
- Views 135
- Downloads 0
Editorial
De-novo cholangiocarcinoma in native common bile duct remnant following OLT for primary sclerosing cholangitis
Primary sclerosing cholangitis (PSC) is a chronic, progressive, inflammatory and obstructive disease of the intra- and extra-hepatic bile ducts of unknown etiology. Currently, orthotopic liver transplantation (OLT) is th...
Assessing risk factors of acute kidney injury after liver transplantation
The socioeconomic impact of hepatitis C infection and liver transplantation in Mexico
The molecular adsorbent recirculating system as a liver support system. Summary of Mexican experience
Aim. The aim of this study was to assess the effects of the molecular absorbent recirculating system (MARS) on patients with acute liver failure (ALF) and liver failure with cirrhosis (AoCLF) as well as in cholestatic pa...